Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Gregory Piazza on The Effect of Enduring Risk Factors in Provoked VTE
Gregory Piazza/LinkedIn
Jan 16, 2026, 12:46

Gregory Piazza on The Effect of Enduring Risk Factors in Provoked VTE

Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on LinkedIn:

”What impact do the type and number of enduring risk factors have on the risk of recurrent venous thromboembolism in patients with an initial provoked event?

A subanalysis of our HI-PRO randomized controlled trials demonstrates just how important recognition of enduring risk is for shared decision making on extended secondary prevention.”

Read the full article here.

Article: Impact of enduring risk factors on efficacy and safety of extended anticoagulation for provoked venous thromboembolism: Post-hoc analysis of the HI-PRO trial

Authors: Mariana Pfeferman, Sina Rashedi, Arvind K. Pandey, Darsiya Krishnathasan, Candrika D. Khairani, Antoine Bejjani, Ruth H. Morrison, Heather Hogan, Junyang Lou, John Fanikos, Nicole Porio, Lisa Rosenbaum, Piotr Sobieszczyk, Zhou Lan, Marie Gerhard-Herman, Umberto Campia, Samuel Z. Goldhaber, Behnood Bikdeli, Gregory Piazza on behalf of the HI-PRO Trial Investigators

Gregory Piazza on The Effect of Enduring Risk Factors in Provoked VTE

Stay updated on all scientific advances with Hemostasis Today.

extended anticoagulation Gregory Piazza Health Hematology Hemostasis Hemostasis News Hemostasis Today HI-PRO Medicine thromboembolism thrombosis VTE
NewsFeed